Lauren MartinAssociateMcDermott Will & Emery Websitewww.mwe.comBlogwww.mwe.com/insightsConnectEmailTwitterLinkedIn312-984-6981 Professional Biography Lauren Martin is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Chicago office. She focuses her practice on intellectual property litigation. More Legal and Business Bylines From Lauren Martin In First Set of Post-Grant Review Decisions, PTAB Strikes Down Patents Based on Alice - (Posted On Wednesday, July 27, 2016) Infringement Counterclaim Confers Subject Matter Jurisdiction - (Posted On Friday, May 27, 2016) New Trial Granted in View of Expert’s Misconduct Despite JMOL on Unrelated Grounds - (Posted On Friday, May 27, 2016) No Institution Based Solely on Unsupported Expert Testimony - (Posted On Wednesday, February 24, 2016) Patent Petitioners: Put All Needed Evidence in Your Petition - (Posted On Friday, January 29, 2016) Federal Circuit Limits the Safe Harbor Provision and the Scope of § 271(g) - (Posted On Thursday, December 24, 2015) Estoppel in Context of Inter Partes Review Proceedings - (Posted On Friday, October 30, 2015) PTAB Findings Get Lots of Deference - (Posted On Wednesday, September 30, 2015) District Courts Have No Jurisdiction to Review PTAB Decision for Interferences Declared after September 15, 2012 - Biogen MA, Inc. v. Japanese Foundation for Cancer Research - (Posted On Thursday, July 02, 2015) “Removed” Versus “Removable” Controls Infringement Inquiry - (Posted On Wednesday, October 29, 2014) Pagination Previous page ‹ Previous Page 2 Next page Next › Current Legal Analysis Updates to the Corporate Transparency Act's Beneficial Ownership Information Reporting Requirements by: Bryce Ellis , Keith Paul Bishop Corporate Transparency Act Enforcement Resumes with Extended Deadlines by: Kathleen M. Porter , Kiernan L. Ignacio CTA Injunction Stayed; FinCEN Extends Reporting Deadlines by: Corporate Compliance, Investigations and Defense Andrews Kurth CTA Revived: Corporate Transparency Act Injunction Lifted by Federal Court and Filing Deadlines Extended by: David E. Weiss , Virginia B. Wilson CMS Rule for CY 2026 Highlights AI, Behavioral Health, Anti-Obesity Drug Coverage, and More by: Helaine I. Fingold , Philo D. Hall Important Corporate Transparency Act Update by: Ryan A. Biller , Jeffrey M. Heller CTA Reporting Requirements Reinstated by: Evgeny Magidenko , Kevin Matz Urgent Update: Corporate Transparency Act Injunction Is Stayed and Mandatory Reporting Requirements Are Applicable to Reporting Companies as Early as January 13, 2025 by: Brian A. Haskel , Robert E. Schiappacasse Upcoming Events Jan 8 2025 Key Proposals in the CY2026 Medicare Advantage and Part D Proposed Rule Jan 8 2025 Whistleblower Protections: Navigating Health Care Employment & Labor Rights Jan 14 2025 What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025 Jan 15 2025 Healthy AI Roundtable Chicago Jan 31 2025 Mass Actions: Bankruptcies, MDLs, Class Actions & Harrington v. Purdue Feb 26 2025 MCLE Triple Play Print
